• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ILA

ISLAND PHARMACEUTICALS LIMITED - News & Media

0.00% ! 18.5¢
Market Cap $43.67M  !
Healthcare Biotechnology
Add to My Watchlist

Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is... Island Pharmaceuticals Ltd is an Australia-based drug repurposing company. The Company is focused on areas of unmet need for antiviral therapeutics to address infectious diseases. Its lead asset is ISLA-101, a drug with a safety profile being repurposed for the prevention and treatment of dengue2 fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. While ISLA-101 is an oral formulation, the Company is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.More

Articles & Videos

Island enrols first subjects for Phase 2b clinical trial for dengue fever drug

Island Pharmaceuticals has enrolled its first four participants in a Phase 2b clinical trial to test ISLA-101 as progress rolls on.

08 Jan 2025 10:16 (AEDT)

Island Pharma's anti-dengue drug trial set to hit Phase 2b in Jan 2025 with FDA happy

Island Pharma has reported witnessing anti-dengue 'activity' in Phase 2a readout results of its ISLA-101 drug.

27 Nov 2024 10:20 (AEDT)

Island Pharmaceuticals (ASX:ILA) receives $1.96m grant to support ISLA-101 clinical development

Island Pharmaceuticals (ASX:ILA) has received a $1.96 million grant to support phase 2a human clinical trials of its ISLA-101 dengue fever treatment.

07 Jul 2023 13:01 (AEST)

Island Pharmaceuticals (ASX:ILA) receives FDA feedback on clinical trial application

Island Pharmaceuticals (ASX:ILA) has received additional FDA feedback following review of its application for its PEACH clinical trial.

01 Feb 2023 15:53 (AEDT)

Bump in the road for Island Pharmaceuticals (ASX:ILA) FDA approval for Isla 101 phase two trial

Island Pharmaceuticals (ASX:ILA) application with the United States Food and Drug Administration for a clinical trial on its dengue fever drug has been place on Clinical Hold.

20 Jan 2023 09:51 (AEDT)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
18.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $43.67M
Open High Low Value Volume
18.5¢ 19.0¢ 17.0¢ $107.4K 601.9K

Buyers (Bids)

No. Vol. Price($)
1 5000 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 58773 1
View Market Depth
Last trade - 15.55pm 13/06/2025 (20 minute delay) ?
ILA (ASX) Chart

Top Stories

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Advance Metals (ASX:AVM) has started its maiden drilling at the Yoquivo Silver-Gold Project in Mexico with a bang...
Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing) Welcome to this week’s HotCopperWire, our market watch podcast!Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through all the week’s biggest news headlines @ and what they mean for Aussie investors.In this Week ...
Iberian expansion: Megado turns to Europe with Spanish copper mines Megado Minerals has added the Iberian Copper Project in Spain to its expanding collection after buying an 80% interest in Iberian Copper.
Gold, Brent Crude spike as Israel strikes Iran in worst-case scenario Israel has come good on its threats to attack Iran on Friday morning, with strikes in Tehran reported by AP and Al Jazeera. Secondary but unconfirmed attacks have also been reported across X (formerly Twitter) today, too.Listen to the HotCopper podcast for in-depth discussions and insights on all...
Resolution's dual-listing to 'expedite growth' – and sets stage for NASDAQ foray Resolution Minerals (ASX:RML) is on the verge of listing on the OTCQB @ oft called the @Venture Market” over in the States @ as it looks to @expedite growth” and @unlock value” through the bold U.S. index expansion.Listen to the Ho...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.